Lupin Q2 Earnings| Profit Rises 74% To Rs 853 Crore, Revenue Up 13%

Pharma major Lupin Ltd reported a robust 74.1% year-on-year rise in its consolidated net profit, reaching Rs 852.63 crore for the July-September quarter of FY25, driven by higher sales. This compares to a profit of Rs 489.67 crore in the same quarter last year. The company’s revenue for the quarter stood at Rs 5,672.73 crore, marking a 12.6% increase from Rs 5,038.56 crore in the corresponding period a year ago. Lupin’s earnings before interest, taxes, depreciation, and amortization (EBITDA) reached Rs 1,382.7 crore, showing a 44.3% increase from Rs 958.2 crore in the same period last year. The EBITDA margin expanded to 25.2%, up from 19.4% year-on-year. Catch Ramesh Swaminathan, Lupin's Group CFO, as he discusses the company’s Q2 performance and growth outlook.